n(6)-carboxymethyllysine has been researched along with Coronary Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Q; Fang, F; Ji, Y; Li, Y; Liu, W; Zhang, W | 1 |
| Cardelo, MP; de la Cruz-Ares, S; García-Rios, A; Gutiérrez-Mariscal, FM; Katsiki, N; López-Miranda, J; Malagón, MM; Pérez-Martínez, P; Torres-Peña, JD; Yubero-Serrano, EM | 1 |
| Arnold, AM; Benkeser, D; Djousse, L; Ix, JH; Kizer, JR; Mukamal, KJ; Psaty, BM; Siscovick, DS; Tracy, RP; Zieman, SJ | 1 |
| Dworacka, M; Szczawińska, K; Szymańska, M; Wierusz-Wysocka, B; Winiarska, H | 1 |
| Berg, TJ; Birkeland, KI; Hanssen, KF; Kilhovd, BK; Thorsby, P | 1 |
3 trial(s) available for n(6)-carboxymethyllysine and Coronary Disease
| Article | Year |
|---|---|
Endothelial Dysfunction and Advanced Glycation End Products in Patients with Newly Diagnosed Versus Established Diabetes: From the CORDIOPREV Study.
Topics: Biomarkers; Carotid Artery Diseases; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diet, Healthy; Endothelium, Vascular; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Olive Oil; Pyruvaldehyde; Single-Blind Method; Vasodilation | 2020 |
Serum N-epsilon-(carboxymethyl)lysine is elevated in nondiabetic coronary heart disease patients.
Topics: Arteriosclerosis; C-Peptide; Carbohydrate Metabolism; Cholesterol, HDL; Coronary Disease; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Female; Glucose; Humans; Islets of Langerhans; Lipid Metabolism; Lipoproteins, HDL; Lysine; Male; Middle Aged; Oxidation-Reduction | 2002 |
Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.
Topics: Aged; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Epitopes; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Multivariate Analysis; Risk Factors | 1999 |
2 other study(ies) available for n(6)-carboxymethyllysine and Coronary Disease
| Article | Year |
|---|---|
Correlation Analysis of CML, sRAGE, and esRAGE and the Measure of Atherosclerosis of Coronary Heart Disease.
Topics: Atherosclerosis; Biomarkers; Coronary Disease; Glycation End Products, Advanced; Humans; Lysine; Receptor for Advanced Glycation End Products | 2022 |
Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults.
Topics: Aged; Albumins; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Cohort Studies; Coronary Disease; Creatinine; Female; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Immunoassay; Incidence; Lysine; Male; Oxidative Stress; Proportional Hazards Models; Stroke; Treatment Outcome | 2014 |